- Home
- ADVM vs AIRT Comparison
ADVM vs AIRT Comparison
Compare ADVM & AIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- AIRT
- Stock Information
- Founded
- ADVM 2006
- AIRT 1980
- Country
- ADVM United States
- AIRT United States
- Employees
- ADVM N/A
- AIRT N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- AIRT Air Freight/Delivery Services
- Sector
- ADVM Health Care
- AIRT Consumer Discretionary
- Exchange
- ADVM Nasdaq
- AIRT Nasdaq
- Market Cap
- ADVM 66.3M
- AIRT 59.6M
- IPO Year
- ADVM 2014
- AIRT N/A
- Fundamental
- Price
- ADVM $3.54
- AIRT $25.42
- Analyst Decision
- ADVM Strong Buy
- AIRT
- Analyst Count
- ADVM 4
- AIRT 0
- Target Price
- ADVM $19.75
- AIRT N/A
- AVG Volume (30 Days)
- ADVM 84.4K
- AIRT 1.5K
- Earning Date
- ADVM 11-03-2025
- AIRT 08-13-2025
- Dividend Yield
- ADVM N/A
- AIRT N/A
- EPS Growth
- ADVM N/A
- AIRT N/A
- EPS
- ADVM N/A
- AIRT N/A
- Revenue
- ADVM $1,000,000.00
- AIRT $296,309,000.00
- Revenue This Year
- ADVM $1,836.70
- AIRT N/A
- Revenue Next Year
- ADVM N/A
- AIRT N/A
- P/E Ratio
- ADVM N/A
- AIRT N/A
- Revenue Growth
- ADVM N/A
- AIRT 5.14
- 52 Week Low
- ADVM $1.78
- AIRT $14.56
- 52 Week High
- ADVM $8.56
- AIRT $26.70
- Technical
- Relative Strength Index (RSI)
- ADVM 71.73
- AIRT 64.96
- Support Level
- ADVM $2.93
- AIRT $22.63
- Resistance Level
- ADVM $3.25
- AIRT $25.50
- Average True Range (ATR)
- ADVM 0.22
- AIRT 0.46
- MACD
- ADVM 0.05
- AIRT 0.21
- Stochastic Oscillator
- ADVM 95.40
- AIRT 98.20
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
About AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.